ART adherence, demographic variables and CD4 outcome among HIV-positive patients on antiretroviral therapy in Chennai, India

Abstract This is an analysis of available chart data recorded by HIV counselors and physicians on patient adherence and CD4 count in 304 patients with HIV who were prescribed antiretroviral therapy (ART) in Chennai, India. HIV counselors had categorized the majority of patients’ adherence as ‘regular’ (74.3%), with a significant minority being categorized as ‘irregular’ (17.8%), or ‘recently missed some doses’ (6.9%). Those categorized as ‘irregular’ had significantly lower CD4 counts than those classified as ‘regular’. Adherence was not associated with any demographic variable; however, it was associated with current CD4 and with change in CD4 since initiation of ART. This association was significant over and above the effects of time on ART. The most common reason for non-adherence was cost (32%), followed by the inability to return for a refill (i.e., patients who were unable or refused to obtain medicines elsewhere) (7.5%). These data suggest that although most patients in this Indian cohort reported regular adherence to ART, a subset admitted to less than regular adherence to ART, and those who admitted to less than regular adherence had worse CD4 outcomes. These data do not support concerns about adherence as a reason to withhold ART in developing countries, nor do they support claims that patients in India who struggle with adherence would be unwilling or unable to admit to non-adherence to health care professionals.

[1]  S. Hira,et al.  High resistance to antiretroviral drugs: the Indian experience , 2004, International journal of STD & AIDS.

[2]  T. Flanigan,et al.  The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India , 2003, AIDS.

[3]  T. Flanigan,et al.  Natural history of human immunodeficiency virus disease in southern India. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  M. Otto,et al.  Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. , 2001, Behaviour research and therapy.

[5]  Susan Swindells,et al.  Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.

[6]  A. Wu,et al.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments , 2000, AIDS care.

[7]  D. Richman,et al.  Predictors of Self‐Reported Adherence and Plasma HIV Concentrations in Patients on Multidrug Antiretroviral Regimens , 2000, Journal of acquired immune deficiency syndromes.

[8]  S. Solomon,et al.  Antiretroviral drugs in the treatment of people living with human immunodeficiency virus: experience in a south Indian tertiary referral centre. , 2000, The Journal of the Association of Physicians of India.

[9]  F. Hecht,et al.  Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population , 2000, AIDS.

[10]  Laura M. Bogart,et al.  Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. , 2000, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[11]  M A Fischl,et al.  Antiretroviral Therapy in Adults Updated Recommendations of the International AIDS Society–USA Panel , 2000 .

[12]  C. Portillo,et al.  The Client Adherence Profiling-Intervention Tailoring (CAP-IT) intervention for enhancing adherence to HIV/AIDS medications: a pilot study. , 2000, The Journal of the Association of Nurses in AIDS Care : JANAC.

[13]  M. Otto,et al.  Life-steps: Applying cognitive behavioral therapy to HIV medication adherence , 1999 .

[14]  Albert Wu,et al.  Optimizing Care for Persons with HIV Infection , 1999, Annals of Internal Medicine.

[15]  M. Wainberg,et al.  Public health implications of antiretroviral therapy and HIV drug resistance. , 1998, JAMA.

[16]  B Clotet,et al.  Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel. , 1998, JAMA.

[17]  J R Ickovics,et al.  Adherence in AIDS clinical trials: a framework for clinical research and clinical care. , 1997, Journal of clinical epidemiology.

[18]  Besch Cl,et al.  Compliance in clinical trials. , 1995 .

[19]  T Pullar,et al.  Compliance in clinical trials. , 1989, Annals of the rheumatic diseases.